A cutting-edge Diabetologia study introduces quantified uncertainty metrics in type 2 diabetes subtyping, nearly doubling prediction for 10-year cardiovascular risk. By embracing clinical ambiguity and using novel entropy measures, clinicians can now better stratify patients and personalize management—ushering in a new era of precision diabetology. To read more Click Here ##Reference## Mori T, Zaharia OP, Straßburger K, et al. Recognising, quantifying and accounting for classification uncertainty in type 2 diabetes subtypes.
Diabetologia. 2025;68(10):2139-2150. What is the main advantage of using subtype uncertainty in T2D care? a) Improved cardiovascular risk prediction b) Routine insulin dose adjustment c) Simplified patient questionnaires d) Elimination of subtype clusters
